Kennedy J W, Stewart D K
Annu Rev Med. 1984;35:513-34. doi: 10.1146/annurev.me.35.020184.002501.
During the past five years percutaneous transluminal coronary angioplasty (PTCA) and intracoronary infusion of streptokinase have been introduced and rapidly accepted as new methods for the treatment of patients with ischemic heart disease. Both of these methods hold great promise for the future. PTCA is established as useful in some selected patients while intracoronary streptokinase is still investigational.
在过去五年中，经皮腔内冠状动脉成形术（PTCA）和冠状动脉内注入链激酶已被引入，并迅速被接受为治疗缺血性心脏病患者的新方法。这两种方法都具有很大的未来前景。PTCA已被确定对某些选定患者有用，而冠状动脉内链激酶仍处于研究阶段。
